Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

October 8, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • REELIN SIGNALLING: SYNAPTOGENESIS TO NETWORK ACTIVITY MODULATION

PGIMER Life Science Job With Rs. 55,000 pm Salary | Scientist (Non-Medical)

SCTIMST Biotech Junior Research Fellow Job | Applications Invited

REELIN SIGNALLING: SYNAPTOGENESIS TO NETWORK ACTIVITY MODULATION
  • BiotechToday
  • World

REELIN SIGNALLING: SYNAPTOGENESIS TO NETWORK ACTIVITY MODULATION

bioxone November 21, 2020November 21, 2020

SUMEDHA GUHA, TECHNO INDIA UNIVERSITY

Reelin is an extracellular glycoprotein that acts as a key regulator for different steps in brain wiring and neuronal cell migration. Reelin signalling is required for axonal targeting, regulation of dendritogenesis, and spine formation in mature neurons. It also plays an important role in ensuring hippocampal integrity, synaptic plasticity, and behaviour. These processes are regulated by Reelin with the help of two receptors –            ApoER2 and VLDLR. These receptors display very specific functions and are differentially expressed throughout the nervous system.

Recent findings reveal a new way of reactivating dendritogenesis in neurological disorders where dendritic arbour complexity is limited, such as in depression, Alzheimer’s disease (AD), and stroke. In recent years, accumulating evidence has linked the Reelin pathway to Alzheimer’s Disease. It has been found that Reelin levels are elevated in the brain of AD patients, but a lower amount of intracellular ApoER2 receptor fragments is detected, suggesting that Reelin signalling is altered in AD.

Previous and more recent studies have displayed the contribution of Reelin signalling to the genetic and behavioural expression of learning and memory. An interesting work using epigenomic analysis revealed that the binding of Reelin to its receptor results in the expressions of immediate early genes involved in synaptic plasticity.

Altogether, these results indicate that Reelin signalling regulates synaptic plasticity, learning, and memory — mainly in the adult hippocampus. Also, alterations in the mechanism of the Reelin pathways in the body can drastically affect these neural processes and behaviour, leading to irreversible neurological diseases. 

Also read: COVID-19 infection in a pregnant woman with liver cytolysis

SOURCE: Reelin functions beyond neuronal migration: from synaptogenesis to network activity modulation;

https://www.sciencedirect.com/science/article/pii/S0959438820301483

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Alzheimer’s disease dendrite depression glycoprotein hippocampus network analysis neuronal network Neurons Reelin Signalling Pathways stroke synapse

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

SCTIMST Biotech Junior Research Fellow Job | Applications Invited

bioxone November 21, 2020

-Shristi Sharma, Team bioXone SCTIMST Biotech JRF Job – Applications Invited. SCTIMST is hiring for a Junior Research Fellow position. MSc candidates are encouraged to attend the interview for a Junior Research Fellow vacancy. Check out all of the details on the same below: View Notification  Title: Junior Research Fellow No. of Posts: One Name […]

Related Post

  • BiotechToday
  • World

Building a chemical blueprint for human blood

bioxone November 16, 2020November 16, 2020

Sagnik Nag, Amity University Kolkata  Our blood serves as an imperative circulatory fluid transporting many chemical substances and respiratory gases throughout the body. There are certain molecules present in the blood which serve as markers providing indications towards the state of our health. Molecules such as hormones and drugs directly or indirectly affect the health […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • FEATURED
  • Latest
  • World

Want to reduce your chance of neurodegenerative diseases? Well get a proper sleep-wake clock

bioxone September 10, 2020September 10, 2020

–Camelia Bhattacharyya, Amity University Kolkata Thomas Dekker once said, “Sleep is the golden chain that ties health and bodies together”, but is sleep the ultimate way? Well no. The function of the glymphatic system which controls the processes involved in the removal of all the wastes (amyloid-beta, etc.) accumulated in the brain during the wake […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Gene therapy clinical trials for rare Angelman syndrome put on hold

bioxone November 7, 2020November 6, 2020

Surupa Chakraborty, Amity University Kolkata A new gene therapy clinical trial for treating Angelman syndrome has been put to hold after two candidates temporarily lost their ability to walk. GTX102, the drug used in the clinical trial was developed by a California-based biopharmaceutical company Ultragenyx, in collaboration with GeneTx, a Florida-based biotech startup. The trial […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy